{
  "abstract": "Background and Importance Clinical trials (CTs) of medicines are complex and require the involvement of different healthcare professionals, including pharmacists.Aim and Objectives The aim of the study was to know the opinions of hospital pharmacists regarding their participation in CTs, taking into account the benefits of their presence in the research team and the obstacles that limit their greater involvement. To the authors’ knowledge, it was the first survey conducted in our country among hospital pharmacists to examine their opinions on this subject.Material and Methods An anonymous online survey (Microsoft Forms) was distributed to 684 hospital pharmacies via email. The survey structure was approved by the Institutional Ethics Committee (118.0043.1.221.2024). The data were collected from September 2024 to January 2025. The survey comprised multiple-choice along with open comment sections for selected questions. The data were analysed using descriptive statistics, primarily presenting the parameters as the number and percentage of responses given in relation to the total number of responses.Results 170 hospital pharmacists responded to the survey. Among them 73 (43%) work in CT centres, while 97 (57%) in hospitals that are not CT centres ( table 1). 161 (95%) respondents think that the participation of pharmacists in CTs is important (97%-I group, 93%-II group). 151 (89%) agree that pharmacists should be more involved (89% for both groups). 137 (81%) consider that pharmacists have the appropriate competence (92%-I group, 72%-II group). 112 (66%) think that pharmacists should be able to be a principal investigator (59%-I group, 71%-II group). The benefits identified by respondents included improvements in: management (78%) and monitoring (73%) of the investigational medicinal product, education of healthcare professionals (66%), involvement of clinical pharmacists (65%), and patient compliance (53%). The obstacles include a lack of: adequate resources (71%), time (60%), relevant knowledge (25%), and motivation (23%).Abstract 6ER-022 Table 1 Characteristics of hospitals (n=170) CT centre (n=73, I group) No CT centre (n=97, II group) Hospital location: MunicipalDistrictRegionalClinical 12(16%)8(11%)23(32%) 30 (41%) 23(24%) 60 (62%) 12(12%)2(2%) Hospital profile: SpecialistOncologyPaediatricSingle-profile 50 (68%) 10(14%)9(12%)4(5%) 81 (84%) 1(1%)015(15%) Number of beds in the hospital: up to 200201-500501-1000>1000 13(18%) 29 (40%) 24(33%)7(10%) 55 (57%) 36(37%)6(6%)0 Number of pharmacists employed in the hospital pharmacy: 2-56-1011-15≥16 28 (38%) 22(30%)12(16%)11(15%) 93 (96%) 4(4%)00 Conclusion and Relevance The vast majority of respondents agree that the participation of pharmacists in CTs is important and support even greater involvement. Respondents pointed out the numerous benefits, both for patient safety and CT quality.Conflict of Interest No conflict of interest",
  "authors": [
    {
      "affiliations": [
        "The University Hospital In Krakow, Hospital Pharmacy, Kraków, Poland"
      ],
      "name": "W Jucha"
    },
    {
      "affiliations": [
        "Jagiellonian University Medical College, Faculty of Pharmacy, Kraków, Poland"
      ],
      "name": "A Rapacz"
    }
  ],
  "title": "6ER-022 The role of the pharmacist in clinical trials of medicines – the perspective of hospital pharmacists – a survey study",
  "uid": "1ae8dff8-bb08-587f-9eef-668c6d20dfd9"
}